Skip to content

Thoracoscopic lung nodule surgery whole process management under ERAS concept

Thoracoscopic lung nodule surgery whole process management under ERAS concept

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074153
Enrollment
Unknown
Registered
2023-07-31
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Nodule

Interventions

Observation group:Detailed management plan for the whole process of surgical treatment of pulmonary nodules under the guidance of ERAS

Sponsors

Beijing Friendship Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-70 years old, (2) assessed with indications for surgery, (3) normal liver and kidney function and coagulation function, (4) patients can tolerate general anesthesia and double-chamber ventilation, (5) according to ASA (American Society of Anesthesiology) standards, anesthesia risk rating is 1-3.

Exclusion criteria

Exclusion criteria: (1) The patient refuses to sign the informed consent form,(2) Other circumstances that are not suitable for surgery

Design outcomes

Primary

MeasureTime frame
Intraoperative complications;Duration of surgery;Amount of intraoperative bleeding;Average length of hospital stay;Average cost;Postoperative complications;

Secondary

MeasureTime frame
Pain score;Cough score;Satisfaction score;

Countries

China

Contacts

Public ContactCui Yong

Beijing Friendship Hospital,Capital Medical University

cywork1@sina.com+86 136 9369 3620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026